AstraZeneca (AZ) has become the latest major drugmaker to announce a significant investment in the US, committing $50bn into ...

Roche’s oral PI3K inhibitor Itovebi (inavolisib) has been approved by the European Commission (EC) as part of a combination ...

The National Institute for Health and Care Excellence (NICE) has recommended ALK’s once-daily immunotherapy tablet to target ...

Tidmarsh has most recently been serving as adjunct professor of paediatrics and neonatology at Stanford University ...

Shared care models, supported by effective communication and digital tools, are helping community nurses like Ashleigh Tropp ...

Discover why diverse patient voices, especially first-time participants, are key to improving clinical trials. Boost ...